Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats
Thércia Guedes Viana, Sara Cristina Hott, Leonardo B.M. Resstel, et al.
Psychopharmacology (2014) Vol. 232, Iss. 9, pp. 1545-1553
Closed Access | Times Cited: 19

Showing 19 citing articles:

Don't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward
Nora D. Volkow, Aidan J. Hampson, Rubén Baler
The Annual Review of Pharmacology and Toxicology (2016) Vol. 57, Iss. 1, pp. 285-308
Open Access | Times Cited: 121
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Francisco Navarrete, María S. García‐Gutiérrez, Rosa Jurado‐Barba, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 104
The effects of trauma on brain and body: A unifying role for the midbrain periaqueductal gray
Braeden A. Terpou, Sherain Harricharan, Margaret C. McKinnon, et al.
Journal of Neuroscience Research (2019) Vol. 97, Iss. 9, pp. 1110-1140
Closed Access | Times Cited: 64
The Endocannabinoid System and Anxiety
Sabrina F. Lisboa, Felipe V. Gomes, Ana Luisa B. Terzian, et al.
Vitamins and hormones (2016), pp. 193-279
Closed Access | Times Cited: 48
Preclinical and Clinical Evidence Supporting Use of Cannabidiol in Psychiatry
Gioacchino Calapai, Carmen Mannucci, İoanna Chinou, et al.
Evidence-based Complementary and Alternative Medicine (2019) Vol. 2019, pp. 1-11
Open Access | Times Cited: 31
Opposing roles of dorsomedial hypothalamic CB1 and TRPV1 receptors in anandamide signaling during the panic-like response elicited in mice by Brazilian rainbow Boidae snakes
Tayllon dos Anjos‐Garcia, Norberto Cysne Coimbra
Psychopharmacology (2019) Vol. 236, Iss. 6, pp. 1863-1874
Closed Access | Times Cited: 30
Whole-exome sequencing and gene-based rare variant association tests suggest that PLA2G4E might be a risk gene for panic disorder
Yoshiro Morimoto, Mihoko Shimada‐Sugimoto, Takeshi Otowa, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 19
Arachidonoyl serotonin (AA-5-HT) modulates general fear-like behavior and inhibits mesolimbic dopamine release
Timothy G. Freels, Deranda B. Lester, Melloni N. Cook
Behavioural Brain Research (2019) Vol. 362, pp. 140-151
Closed Access | Times Cited: 16
Hypothalamic endocannabinoid signalling modulates aversive responses related to panic attacks
Thércia Guedes Viana, Juliana dos Reis Bastos, Rayssa B. Costa, et al.
Neuropharmacology (2019) Vol. 148, pp. 284-290
Closed Access | Times Cited: 16
Cannabidiol-induced panicolytic-like effects and fear-induced antinociception impairment: the role of the CB1 receptor in the ventromedial hypothalamus
Asmat Ullah Khan, Luiz Luciano Falconi‐Sobrinho, Tayllon dos Anjos‐Garcia, et al.
Psychopharmacology (2020) Vol. 237, Iss. 4, pp. 1063-1079
Closed Access | Times Cited: 15
The endocannabinoid system, a novel and key participant in acupuncture’s multiple beneficial effects
Bo Hu, Fuhai Bai, Lize Xiong, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 77, pp. 340-357
Closed Access | Times Cited: 16
Associations of plasma leptin to clinical manifestations in reproductive aged female patients with panic disorder
Vasilios G. Masdrakis, Charalabos Papageorgiou, Manolis Markianos
Psychiatry Research (2017) Vol. 255, pp. 161-166
Closed Access | Times Cited: 13
Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey
Pedro H. Gobira, Ana F. Almeida‐Santos, Francisco Silveira Guimarães, et al.
European Neuropsychopharmacology (2015) Vol. 26, Iss. 1, pp. 15-22
Closed Access | Times Cited: 12
Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack
Luara A. Batista, Andréa Siqueira Haibara, Luiz Carlos Schenberg, et al.
Behavioural Brain Research (2016) Vol. 317, pp. 508-514
Closed Access | Times Cited: 9
Cannabinoid CB1 receptors mediate the anxiolytic effects induced by systemic alprazolam and intra-periaqueductal gray 5-HT1A receptor activation
Luara A. Batista, Fabrício A. Moreira
Neuroscience Letters (2019) Vol. 703, pp. 5-10
Closed Access | Times Cited: 6
Mu-opioid and CB1 cannabinoid receptors of the dorsal periaqueductal gray interplay in the regulation of fear response, but not antinociception
Manuella Machado Godoi, Hélio Zangrossi, Joice Maria da Cunha, et al.
Pharmacology Biochemistry and Behavior (2020) Vol. 194, pp. 172938-172938
Open Access | Times Cited: 3
Anti-aversive effect of 2-arachidonoylglycerol in the dorsolateral periaqueductal gray of male rats in contextual fear conditioning and Vogel tests
Rayssa C. Briânis, Rita Lima, Fabrício A. Moreira, et al.
Behavioural Pharmacology (2021) Vol. 33, Iss. 2&3, pp. 213-221
Closed Access | Times Cited: 2
The innate defensive behaviour and unconditioned fear-induced antinociception evoked by NMDA receptor activation in the medial hypothalamus are modulated by the intradiencephalic treatment with cannabidiol: the role of CB1 cannabinoid receptor
Asmat Ullah Khan
(2019)
Open Access
Intravenous doxapram administration as a potential model of panic attacks in rats
Luara A. Batista, Jadna Bogado Lopes, Rayssa C. Briânis, et al.
Behavioural Pharmacology (2020) Vol. 32, Iss. 2&3, pp. 182-193
Closed Access
Page 1

Scroll to top